Verve
ScienceGet the app
Evidence-based fitness tracking

Track the number that predicts how long you live.

Verve measures MET-hours and cardiorespiratory fitness — the same metrics used to assess mortality risk in peer-reviewed research — with every threshold in the app traced to a cited source.

13%lower all-cause mortality per +1 MET improvementKodama et al, JAMA 2009
mortality difference, Low to Elite fitnessMandsager et al, Cleveland Clinic 2018
23peer-reviewed studies behind the app's thresholdsVerve Science page

What Verve actually tracks

Six pillars, each backed by named, checkable research — not a proprietary score nobody can audit.

The Ascent

Your week, drawn as a climb

Moderate-to-vigorous minutes climb against WHO, personal, and AHA altitude lines — a flag plants the moment you cross each one. No ring, no streak to break.

Cardiorespiratory Fitness

6 validated test methods

Cooper, 1.5-mile run, Rockport walk, CPET and more — classified against ACSM/Cooper norms under 40, Cleveland Clinic treadmill data (Mandsager 2018) at 40 and over.

Zone 2 Training

Your own heart-rate band, not a guess

Karvonen heart-rate-reserve zones computed from your age, resting HR, and fitness — not a fixed 220-minus-age formula.

Heart Health

ApoB · LDL-C · Lp(a) · hs-CRP

Screening bands from ESC/EAS, NCEP ATP III, and AHA/CDC guidelines — every threshold traced to its source, none of it a treatment target.

Body Phenotyping

Metabolic health + the Functional Combine

Metabolic syndrome screening (Alberti 2009) alongside a 6-test functional battery — grip, balance, chair stand, gait speed, and SPPB.

The Grade

This week vs. your own usual

Two bars, one sentence — no percentage, no black-box score, no comparison to anyone but you.

No unciteable numbers

Every threshold, traced to its source.

No proprietary "recovery" or "strain" score you can't check the math on — every threshold links to the paper it came from.

Read the full evidence base →
ApoBmg/dL
Optimal≤ 79
Borderline80–99
Elevated≥ 100

ESC/EAS 2019 Guidelines for the Management of Dyslipidaemias — Mach F et al, Eur Heart J 2020;41:111–188.